CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE

CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE was reported 3264 times

CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NIPPLE INFECTION 3 0.0769
1 COMPULSIVE HANDWASHING 2 0.0769
2 BENIGN LARYNGEAL NEOPLASM 2 0.0645
3 GRANULOMATOUS DERMATITIS 14 0.0574
4 ACTH STIMULATION TEST ABNORMAL 2 0.0571
5 SEBACEOUS HYPERPLASIA 5 0.0382
6 POIKILODERMA 3 0.0278
7 MYRINGITIS 2 0.0270
8 ATYPICAL FIBROXANTHOMA 2 0.0267
9 ERYTHRODERMIC PSORIASIS 18 0.0218
10 TOPICAL STEROID WITHDRAWAL REACTION 8 0.0206
11 LOOSE BODY IN JOINT 5 0.0188
12 LENTIGO 9 0.0181
13 CUTANEOUS SARCOIDOSIS 7 0.0162
14 CALCIUM METABOLISM DISORDER 3 0.0160
15 ACANTHOSIS 5 0.0152
16 OLIGOARTHRITIS 3 0.0151
17 NAIL PSORIASIS 8 0.0129
18 FACIAL OPERATION 2 0.0124
19 HEPATITIS ALCOHOLIC 4 0.0122
20 DYSPLASTIC NAEVUS 4 0.0111
21 SEBORRHOEIC KERATOSIS 16 0.0110
22 GUTTATE PSORIASIS 9 0.0110
23 ARTERIAL INSUFFICIENCY 2 0.0108
24 GASTROINTESTINAL ANGIODYSPLASIA HAEMORRHAGIC 2 0.0103
25 ALCOHOLIC PANCREATITIS 2 0.0103
26 HAEMATOMA INFECTION 5 0.0087
27 FIBROUS HISTIOCYTOMA 3 0.0085
28 MILIA 3 0.0083
29 ESCHERICHIA PYELONEPHRITIS 2 0.0077
30 HYPERADRENOCORTICISM 2 0.0073
31 COVID-19 IMMUNISATION 6 0.0072
32 PHOTODERMATOSIS 3 0.0071
33 REBOUND PSORIASIS 4 0.0069
34 GRANULOMA ANNULARE 5 0.0068
35 CIRRHOSIS ALCOHOLIC 3 0.0066
36 ACTINIC KERATOSIS 17 0.0065
37 ALCOHOL WITHDRAWAL SYNDROME 5 0.0057
38 INTERTRIGO 3 0.0055
39 INTRACRANIAL HAEMATOMA 3 0.0053
40 BURNOUT SYNDROME 3 0.0053
41 NAIL BED BLEEDING 3 0.0053
42 INTRACRANIAL TUMOUR HAEMORRHAGE 2 0.0052
43 CAMPYLOBACTER GASTROENTERITIS 3 0.0051
44 B-CELL LYMPHOMA 17 0.0050
45 BRAIN COMPRESSION 2 0.0050
46 PUSTULAR PSORIASIS 17 0.0049
47 PSORIASIS 645 0.0049
48 STEROID WITHDRAWAL SYNDROME 5 0.0049
49 LICHENIFICATION 2 0.0049
50 MYOCARDIAL FIBROSIS 4 0.0048
51 GENITAL BURNING SENSATION 4 0.0046
52 NEOPLASM SKIN 7 0.0045
53 NECK DEFORMITY 2 0.0045
54 MUSCLE SWELLING 4 0.0043
55 OPHTHALMIC MIGRAINE 3 0.0043
56 OTITIS EXTERNA 5 0.0041
57 DACTYLITIS 4 0.0041
58 GLOMERULAR FILTRATION RATE INCREASED 3 0.0036
59 DYSCHROMATOPSIA 3 0.0036
60 BODY TINEA 2 0.0036
61 ADRENAL SUPPRESSION 3 0.0036
62 SKIN PLAQUE 30 0.0036
63 OSTEOCHONDROSIS 4 0.0034
64 EXCESSIVE CERUMEN PRODUCTION 2 0.0032
65 LIPOHYPERTROPHY 2 0.0032
66 SOLAR LENTIGO 3 0.0032
67 GLIOMA 2 0.0031
68 VULVOVAGINAL CANDIDIASIS 4 0.0030
69 SKIN ATROPHY 17 0.0030
70 DERMATITIS PSORIASIFORM 6 0.0029
71 PSORIATIC ARTHROPATHY 119 0.0029
72 ANGULAR CHEILITIS 2 0.0029
73 URETEROLITHIASIS 3 0.0029
74 SKIN STRIAE 4 0.0027
75 PULMONARY SARCOIDOSIS 3 0.0027
76 GINGIVAL ABSCESS 2 0.0027
77 INFECTED SKIN ULCER 5 0.0026
78 COMPLICATION OF PREGNANCY 2 0.0026
79 DEBRIDEMENT 2 0.0026
80 ADRENOCORTICAL INSUFFICIENCY ACUTE 5 0.0026
81 PAPULE 18 0.0026
82 PUSTULE 6 0.0025
83 TINEA PEDIS 4 0.0025
84 SEBORRHOEIC DERMATITIS 4 0.0024
85 GIANT CELL ARTERITIS 2 0.0024
86 ADENOMA BENIGN 2 0.0023
87 HEPATIC LESION 10 0.0023
88 MELANOCYTIC NAEVUS 10 0.0023
89 KYPHOSIS 4 0.0023
90 ANOGENITAL WARTS 2 0.0022
91 ERYSIPELAS 11 0.0022
92 HAEMORRHAGIC ARTERIOVENOUS MALFORMATION 2 0.0021
93 CHORIORETINOPATHY 3 0.0021
94 ANTINUCLEAR ANTIBODY INCREASED 2 0.0021
95 ANAL CANCER 2 0.0021
96 HYPOTHALAMO-PITUITARY DISORDER 3 0.0021
97 MENTAL FATIGUE 3 0.0020
98 HAEMANGIOMA OF LIVER 2 0.0020
99 MEAN CELL VOLUME DECREASED 3 0.0019
100 SQUAMOUS CELL CARCINOMA 18 0.0019
101 NASAL INFLAMMATION 2 0.0019
102 PHARYNGEAL PARAESTHESIA 3 0.0019
103 ALLERGY TO ANIMAL 2 0.0019
104 GALLBLADDER ENLARGEMENT 2 0.0019
105 INFECTION SUSCEPTIBILITY INCREASED 4 0.0018
106 SQUAMOUS CELL CARCINOMA OF SKIN 11 0.0018
107 MACULE 5 0.0018
108 BENIGN NEOPLASM 2 0.0018
109 FOLATE DEFICIENCY 2 0.0017
110 SINUS PAIN 4 0.0017
111 DEVICE DISPENSING ERROR 2 0.0017
112 INDURATION 3 0.0017
113 MEAN CELL HAEMOGLOBIN DECREASED 3 0.0016
114 SEBORRHOEA 6 0.0016
115 DERMAL CYST 4 0.0016
116 HELICOBACTER GASTRITIS 2 0.0016
117 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0016
118 SKIN LESION 43 0.0016
119 DACRYOSTENOSIS ACQUIRED 2 0.0015
120 PYELONEPHRITIS ACUTE 3 0.0015
121 SYNOVIAL CYST 7 0.0015
122 SKIN INFECTION 17 0.0015
123 MUCOSAL DRYNESS 3 0.0015
124 SKIN HAEMORRHAGE 22 0.0015
125 INVASIVE DUCTAL BREAST CARCINOMA 4 0.0015
126 SKIN INDURATION 3 0.0014
127 LATENT TUBERCULOSIS 3 0.0014
128 THERMAL BURN 10 0.0014
129 CELLULITIS 69 0.0014
130 GENITAL PAIN 2 0.0014
131 ATYPICAL PNEUMONIA 4 0.0013
132 PAIN OF SKIN 36 0.0013
133 CHEST X-RAY ABNORMAL 4 0.0013
134 CALCULUS URINARY 2 0.0013
135 ROSACEA 6 0.0013
136 SKIN HYPERPIGMENTATION 11 0.0013
137 BACTERIAL VAGINOSIS 2 0.0013
138 PRURITUS GENITAL 3 0.0013
139 VULVOVAGINAL MYCOTIC INFECTION 5 0.0013
140 STREPTOCOCCAL INFECTION 7 0.0013
141 SKIN FRAGILITY 3 0.0012
142 SKIN FISSURES 24 0.0012
143 DENTAL IMPLANTATION 2 0.0012
144 LUPUS-LIKE SYNDROME 11 0.0012
145 OTITIS MEDIA 4 0.0012
146 PHARYNGITIS STREPTOCOCCAL 13 0.0012
147 ONYCHOMADESIS 5 0.0012
148 TONGUE ULCERATION 4 0.0012
149 ANGLE CLOSURE GLAUCOMA 3 0.0012
150 MATERNAL EXPOSURE BEFORE PREGNANCY 8 0.0012
151 ONYCHOCLASIS 8 0.0012
152 JOINT EFFUSION 8 0.0012
153 ACUTE SINUSITIS 2 0.0012
154 INJECTION SITE VESICLES 7 0.0012
155 HORDEOLUM 5 0.0012
156 BASAL CELL CARCINOMA 18 0.0012
157 SKIN SWELLING 10 0.0012
158 DERMATITIS EXFOLIATIVE GENERALISED 4 0.0011
159 FOLLICULITIS 12 0.0011
160 ALOPECIA AREATA 2 0.0011
161 ORAL CANDIDIASIS 15 0.0011
162 SKIN WEEPING 4 0.0011
163 EAR CONGESTION 3 0.0011
164 SKIN WRINKLING 3 0.0011
165 DERMATITIS 23 0.0011
166 EOSINOPHIL COUNT INCREASED 9 0.0011
167 UMBILICAL HERNIA 5 0.0011
168 HYPERTENSIVE HEART DISEASE 2 0.0011
169 SKIN ABRASION 5 0.0011
170 HEPATOCELLULAR CARCINOMA 8 0.0011
171 SCRATCH 11 0.0010
172 NAIL DISORDER 9 0.0010
173 LUMBAR SPINAL STENOSIS 3 0.0010
174 ORAL INFECTION 4 0.0010
175 OESOPHAGEAL CANDIDIASIS 4 0.0010
176 DERMATITIS EXFOLIATIVE 5 0.0010
177 BONE MARROW DISORDER 3 0.0010
178 SKIN DISORDER 33 0.0010
179 PROSTATITIS 3 0.0010
180 MASTICATION DISORDER 3 0.0010
181 RECTAL CANCER 3 0.0010
182 MALIGNANT MELANOMA 13 0.0010
183 FOETAL DEATH 5 0.0010
184 CUSHINGOID 3 0.0009
185 SKIN EROSION 3 0.0009
186 ANAL ABSCESS 5 0.0009
187 GASTRIC BYPASS 2 0.0009
188 SUSPECTED COVID-19 3 0.0009
189 ENDOMETRIAL CANCER 2 0.0009
190 HYPERKERATOSIS 5 0.0009
191 BRAIN NEOPLASM MALIGNANT 4 0.0009
192 DIVERTICULUM INTESTINAL HAEMORRHAGIC 2 0.0009
193 BRAIN OPERATION 2 0.0009
194 HAEMANGIOMA 2 0.0009
195 AORTIC STENOSIS 3 0.0009
196 IMPLANT SITE INFECTION 2 0.0009
197 GASTRITIS EROSIVE 4 0.0009
198 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
199 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 2 0.0008
200 SKIN EXFOLIATION 71 0.0008
201 MUSCULOSKELETAL CHEST PAIN 13 0.0008
202 BLOOD PHOSPHORUS DECREASED 3 0.0008
203 RENAL CELL CARCINOMA 4 0.0008
204 CARTILAGE INJURY 2 0.0008
205 PIGMENTATION DISORDER 5 0.0008
206 FOOT OPERATION 4 0.0008
207 INFLAMMATORY MARKER INCREASED 4 0.0008
208 CARDIAC DYSFUNCTION 3 0.0008
209 INJECTION SITE ABSCESS 2 0.0008
210 SPINAL OSTEOARTHRITIS 7 0.0008
211 PARANASAL SINUS DISCOMFORT 3 0.0008
212 ABDOMINAL INFECTION 2 0.0008
213 OESOPHAGEAL ULCER 3 0.0008
214 THERAPEUTIC PRODUCT INEFFECTIVE 3 0.0008
215 WOUND SECRETION 3 0.0008
216 EXFOLIATIVE RASH 2 0.0008
217 FURUNCLE 6 0.0008
218 PRODUCT PRESCRIBING ERROR 18 0.0008
219 PRODUCT DISTRIBUTION ISSUE 7 0.0008
220 SKIN PAPILLOMA 3 0.0007
221 ABDOMINAL MASS 2 0.0007
222 POSTOPERATIVE WOUND INFECTION 5 0.0007
223 NEURALGIA 18 0.0007
224 MATERNAL EXPOSURE DURING BREAST FEEDING 3 0.0007
225 POST PROCEDURAL INFECTION 6 0.0007
226 ABDOMINAL RIGIDITY 2 0.0007
227 NORMAL NEWBORN 4 0.0007
228 PRODUCT PHYSICAL CONSISTENCY ISSUE 4 0.0007
229 SYNOVITIS 13 0.0007
230 CHOLECYSTITIS INFECTIVE 2 0.0007
231 AUTOIMMUNE HEPATITIS 5 0.0007
232 ANAL HAEMORRHAGE 2 0.0007
233 UPPER RESPIRATORY TRACT INFECTION 33 0.0007
234 CANDIDA INFECTION 12 0.0007
235 HEPATOCELLULAR INJURY 10 0.0007
236 LOCALISED INFECTION 17 0.0007
237 LEFT VENTRICULAR HYPERTROPHY 3 0.0007
238 PRODUCT SUPPLY ISSUE 5 0.0007
239 HEPATIC STEATOSIS 13 0.0007
240 PYELONEPHRITIS 6 0.0007
241 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3 0.0007
242 CHAPPED LIPS 3 0.0007
243 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
244 BILIARY COLIC 2 0.0007
245 TONGUE DISCOLOURATION 3 0.0007
246 GASTROENTERITIS 10 0.0007
247 ANKYLOSING SPONDYLITIS 9 0.0007
248 TOOTH INFECTION 9 0.0007
249 SEXUAL DYSFUNCTION 8 0.0007
250 GRIP STRENGTH DECREASED 6 0.0007
251 INFLAMMATION 35 0.0007
252 ENERGY INCREASED 4 0.0007
253 GLUCOSE TOLERANCE IMPAIRED 4 0.0007
254 ODYNOPHAGIA 4 0.0007
255 HYPERLIPIDAEMIA 8 0.0007
256 FREQUENT BOWEL MOVEMENTS 18 0.0007
257 CEREBROVASCULAR DISORDER 2 0.0007
258 NASAL CONGESTION 39 0.0007
259 ARTHRITIS 52 0.0007
260 ADRENAL INSUFFICIENCY 8 0.0007
261 ECTOPIC PREGNANCY 2 0.0006
262 FIBROSIS 2 0.0006
263 PRODUCTIVE COUGH 31 0.0006
264 CONCOMITANT DISEASE AGGRAVATED 4 0.0006
265 DIASTOLIC DYSFUNCTION 2 0.0006
266 MASS 9 0.0006
267 SECRETION DISCHARGE 8 0.0006
268 PRODUCT ADMINISTRATION INTERRUPTED 5 0.0006
269 GESTATIONAL DIABETES 3 0.0006
270 SUBCUTANEOUS ABSCESS 3 0.0006
271 THERAPY NON-RESPONDER 28 0.0006
272 RASH VESICULAR 3 0.0006
273 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 44 0.0006
274 LOWER RESPIRATORY TRACT INFECTION 28 0.0006
275 SCAB 7 0.0006
276 APPLICATION SITE BURN 3 0.0006
277 LIGAMENT SPRAIN 6 0.0006
278 NEAR DEATH EXPERIENCE 2 0.0006
279 ABDOMINAL TENDERNESS 3 0.0006
280 ACUTE CORONARY SYNDROME 5 0.0006
281 SKIN MASS 4 0.0006
282 NEPHRITIS 2 0.0006
283 SPLENOMEGALY 7 0.0006
284 DYSLIPIDAEMIA 3 0.0006
285 HEPATIC CIRRHOSIS 11 0.0006
286 LIVER FUNCTION TEST ABNORMAL 17 0.0006
287 HEPATIC FIBROSIS 2 0.0006
288 VARICOSE VEIN 3 0.0006
289 RESPIRATION ABNORMAL 4 0.0006
290 DIVERTICULITIS 16 0.0006
291 SINUSITIS 59 0.0006
292 TONSILLITIS 3 0.0006
293 BLOOD CALCIUM INCREASED 5 0.0006
294 FUNGAL INFECTION 19 0.0006
295 IMMUNOSUPPRESSION 5 0.0006
296 BONE EROSION 2 0.0006
297 ORAL HERPES 11 0.0006
298 OROPHARYNGEAL PAIN 52 0.0006
299 CONJUNCTIVAL HYPERAEMIA 2 0.0006
300 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
301 GASTROINTESTINAL INFECTION 5 0.0006
302 TOOTHACHE 10 0.0006
303 PRODUCT DOSE OMISSION 36 0.0006
304 MOUTH HAEMORRHAGE 4 0.0005
305 DENTAL CARIES 6 0.0005
306 SKIN ULCER 14 0.0005
307 ARTHROPOD BITE 4 0.0005
308 HEART RATE ABNORMAL 3 0.0005
309 PULMONARY MASS 8 0.0005
310 LEUKOENCEPHALOPATHY 2 0.0005
311 APPENDICITIS 5 0.0005
312 ANGIOPATHY 3 0.0005
313 CHRONIC SINUSITIS 2 0.0005
314 NASOPHARYNGITIS 98 0.0005
315 LACERATION 5 0.0005
316 ABORTION INDUCED 5 0.0005
317 DERMATITIS CONTACT 6 0.0005
318 EAR INFECTION 14 0.0005
319 AORTIC ANEURYSM 4 0.0005
320 NEPHROLITHIASIS 24 0.0005
321 DRUG EFFECT INCOMPLETE 19 0.0005
322 MUSCULOSKELETAL DISCOMFORT 9 0.0005
323 SINUS CONGESTION 7 0.0005
324 HYPERCHOLESTEROLAEMIA 5 0.0005
325 ECZEMA 27 0.0005
326 APHTHOUS ULCER 4 0.0005
327 ERYTHEMA 106 0.0005
328 VASCULITIS 6 0.0005
329 DECREASED IMMUNE RESPONSIVENESS 5 0.0005
330 PLEURISY 3 0.0005
331 CHOLECYSTITIS 6 0.0005
332 RASH ERYTHEMATOUS 24 0.0005
333 ABSCESS 8 0.0005
334 BLEPHARITIS 2 0.0005
335 RHINITIS 4 0.0005
336 EMPHYSEMA 5 0.0005
337 GALLBLADDER OPERATION 2 0.0005
338 APPLICATION SITE DISCOLOURATION 2 0.0005
339 ORAL PAIN 11 0.0005
340 TOOTH ABSCESS 5 0.0005
341 ASPHYXIA 4 0.0005
342 MENISCUS INJURY 3 0.0005
343 RASH MACULAR 17 0.0005
344 ANAPHYLACTOID REACTION 2 0.0005
345 LIMB DISCOMFORT 15 0.0005
346 CHOLANGITIS 3 0.0005
347 CYST 6 0.0005
348 OLIGURIA 3 0.0005
349 TREATMENT FAILURE 40 0.0005
350 HYPOKINESIA 7 0.0005
351 NASAL DRYNESS 3 0.0005
352 PHOTOPHOBIA 9 0.0005
353 DERMATITIS ALLERGIC 6 0.0005
354 MUSCLE ATROPHY 6 0.0005
355 THERAPEUTIC RESPONSE CHANGED 3 0.0005
356 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
357 FACIAL PARALYSIS 4 0.0005
358 INTERVERTEBRAL DISC DISORDER 2 0.0005
359 SKIN CANCER 10 0.0005
360 METASTATIC NEOPLASM 2 0.0005
361 PRURITUS 178 0.0005
362 APPLICATION SITE VESICLES 3 0.0005
363 PRURITUS GENERALISED 10 0.0005
364 LOCAL SWELLING 8 0.0005
365 POLYP 3 0.0005
366 IMMUNE SYSTEM DISORDER 6 0.0005
367 STAPHYLOCOCCAL INFECTION 15 0.0005
368 INJECTION SITE URTICARIA 11 0.0004
369 BRONCHITIS 33 0.0004
370 OCULAR DISCOMFORT 5 0.0004
371 BRONCHIECTASIS 3 0.0004
372 METASTASES TO LYMPH NODES 3 0.0004
373 EYE INFECTION 5 0.0004
374 HIDRADENITIS 4 0.0004
375 ABDOMINAL HERNIA 2 0.0004
376 EAR DISORDER 2 0.0004
377 RETINAL DETACHMENT 4 0.0004
378 INCREASED TENDENCY TO BRUISE 4 0.0004
379 OVARIAN CANCER 4 0.0004
380 ARTHRITIS INFECTIVE 2 0.0004
381 EXTRASYSTOLES 3 0.0004
382 WOUND 12 0.0004
383 MOUTH ULCERATION 9 0.0004
384 SKIN REACTION 6 0.0004
385 OSTEOARTHRITIS 18 0.0004
386 RESPIRATORY TRACT INFECTION 11 0.0004
387 COLITIS MICROSCOPIC 2 0.0004
388 BACTERAEMIA 5 0.0004
389 VIRAL INFECTION 14 0.0004
390 ENDOMETRIOSIS 2 0.0004
391 LIMB OPERATION 2 0.0004
392 CHOLESTASIS 8 0.0004
393 TYPE 2 DIABETES MELLITUS 14 0.0004
394 VISUAL FIELD DEFECT 3 0.0004
395 HERNIA 8 0.0004
396 GUILLAIN-BARRE SYNDROME 2 0.0004
397 DRY SKIN 55 0.0004
398 APPLICATION SITE PAIN 9 0.0004
399 ASCITES 12 0.0004
400 BODY TEMPERATURE DECREASED 4 0.0004
401 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
402 IMMUNODEFICIENCY 6 0.0004
403 INJECTION SITE INFLAMMATION 2 0.0004
404 INJECTION SITE BRUISING 32 0.0004
405 LYMPHADENOPATHY 14 0.0004
406 DYSPHORIA 2 0.0004
407 CORONARY ARTERIAL STENT INSERTION 2 0.0004
408 TROPONIN INCREASED 3 0.0004
409 GOUT 7 0.0004
410 JOINT SWELLING 47 0.0004
411 DIFFUSE LARGE B-CELL LYMPHOMA 3 0.0004
412 INJECTION SITE WARMTH 8 0.0004
413 ATRIOVENTRICULAR BLOCK 3 0.0004
414 GASTROENTERITIS VIRAL 7 0.0004
415 RHINORRHOEA 25 0.0004
416 INTENTIONAL DOSE OMISSION 11 0.0004
417 TENDERNESS 4 0.0004
418 PETECHIAE 4 0.0004
419 NODULE 5 0.0004
420 JOINT STIFFNESS 10 0.0004
421 BEDRIDDEN 5 0.0004
422 PULMONARY CONGESTION 5 0.0004
423 RENAL CANCER 18 0.0004
424 RENAL CYST 3 0.0004
425 RESPIRATORY TRACT CONGESTION 6 0.0004
426 BLOOD DISORDER 3 0.0004
427 FOOD POISONING 2 0.0004
428 COMPRESSION FRACTURE 2 0.0004
429 ANAL FISSURE 2 0.0004
430 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 67 0.0004
431 MYASTHENIA GRAVIS 3 0.0004
432 BEHAVIOUR DISORDER 2 0.0004
433 ABDOMINAL DISCOMFORT 62 0.0004
434 UVEITIS 5 0.0004
435 SKIN LACERATION 4 0.0004
436 POLYURIA 3 0.0004
437 OESOPHAGITIS 4 0.0004
438 HYPERAESTHESIA 3 0.0004
439 POST PROCEDURAL COMPLICATION 7 0.0004
440 CHOKING SENSATION 2 0.0004
441 FOOT DEFORMITY 4 0.0004
442 INJECTION SITE INJURY 2 0.0004
443 EAR PAIN 7 0.0004
444 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
445 LIVE BIRTH 3 0.0004
446 THERAPEUTIC PRODUCT EFFECT DECREASED 16 0.0004
447 CARPAL TUNNEL SYNDROME 5 0.0004
448 KIDNEY INFECTION 7 0.0004
449 BLISTER 20 0.0004
450 SEASONAL ALLERGY 5 0.0004
451 SWELLING FACE 23 0.0004
452 HEPATITIS 9 0.0004
453 DIARRHOEA 226 0.0003
454 NEUROLOGICAL SYMPTOM 2 0.0003
455 SKIN BURNING SENSATION 25 0.0003
456 COVID-19 61 0.0003
457 THERAPEUTIC RESPONSE DECREASED 21 0.0003
458 URINARY TRACT INFECTION 59 0.0003
459 CYSTITIS 11 0.0003
460 HYPERVENTILATION 2 0.0003
461 METABOLIC DISORDER 2 0.0003
462 PERIPHERAL SWELLING 53 0.0003
463 ARTHROPATHY 19 0.0003
464 GROIN PAIN 3 0.0003
465 ARTHRALGIA 142 0.0003
466 OSTEOPOROSIS 14 0.0003
467 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
468 ACUTE MYOCARDIAL INFARCTION 10 0.0003
469 MATERNAL EXPOSURE DURING PREGNANCY 30 0.0003
470 ISCHAEMIC STROKE 6 0.0003
471 CHOLELITHIASIS 11 0.0003
472 DRUG EFFECT DECREASED 18 0.0003
473 HEARING IMPAIRED 2 0.0003
474 CHILLS 39 0.0003
475 LIMB INJURY 9 0.0003
476 LIP DRY 3 0.0003
477 BURSITIS 4 0.0003
478 FOETAL GROWTH RESTRICTION 2 0.0003
479 DISCOMFORT 20 0.0003
480 BRAIN NEOPLASM 3 0.0003
481 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
482 UROSEPSIS 3 0.0003
483 NERVE COMPRESSION 3 0.0003
484 ABORTION SPONTANEOUS 13 0.0003
485 TENDON RUPTURE 4 0.0003
486 HYPERCALCAEMIA 4 0.0003
487 CONJUNCTIVITIS 6 0.0003
488 INFLUENZA 36 0.0003
489 LUNG INFECTION 5 0.0003
490 RASH 140 0.0003
491 ILLNESS 33 0.0003
492 INJECTION SITE DISCOLOURATION 4 0.0003
493 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
494 BRAIN FOG 5 0.0003
495 INFECTION 46 0.0003
496 COLITIS 12 0.0003
497 SPUTUM DISCOLOURED 3 0.0003
498 PNEUMOTHORAX 5 0.0003
499 SLEEP APNOEA SYNDROME 6 0.0003
500 HEADACHE 196 0.0003
501 CARDIAC FLUTTER 2 0.0003
502 INCOHERENT 2 0.0003
503 HAEMATOMA 8 0.0003
504 HEPATIC ENZYME INCREASED 21 0.0003
505 HERPES SIMPLEX 2 0.0003
506 VITAMIN D DEFICIENCY 3 0.0003
507 DEAFNESS 8 0.0003
508 APPLICATION SITE ERYTHEMA 8 0.0003
509 KNEE OPERATION 3 0.0003
510 SARS-COV-2 TEST POSITIVE 4 0.0003
511 CATARACT 18 0.0003
512 THERAPEUTIC RESPONSE SHORTENED 10 0.0003
513 HAIR TEXTURE ABNORMAL 4 0.0003
514 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
515 INJECTION SITE PRURITUS 20 0.0003
516 JOINT RANGE OF MOTION DECREASED 4 0.0003
517 BREAST MASS 2 0.0003
518 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
519 MUSCULOSKELETAL STIFFNESS 26 0.0003
520 PAIN IN EXTREMITY 87 0.0003
521 SUBARACHNOID HAEMORRHAGE 3 0.0003
522 BLOOD TESTOSTERONE DECREASED 2 0.0003
523 EAR DISCOMFORT 3 0.0003
524 MOBILITY DECREASED 21 0.0003
525 ECCHYMOSIS 2 0.0003
526 INFLUENZA LIKE ILLNESS 24 0.0003
527 PROSTATIC SPECIFIC ANTIGEN INCREASED 4 0.0003
528 ACNE 22 0.0003
529 INJECTION SITE SWELLING 22 0.0003
530 NECK PAIN 16 0.0003
531 RENAL PAIN 3 0.0003
532 INJECTION SITE ERYTHEMA 35 0.0003
533 DIVERTICULUM 2 0.0003
534 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 20 0.0003
535 JOINT INJURY 6 0.0003
536 AGEUSIA 7 0.0003
537 IRRITABLE BOWEL SYNDROME 6 0.0003
538 GASTROINTESTINAL DISORDER 25 0.0003
539 PANCREATIC CARCINOMA 8 0.0003
540 ABDOMINAL PAIN LOWER 7 0.0003
541 ANOSMIA 4 0.0003
542 OSTEOMYELITIS 5 0.0003
543 BACK INJURY 3 0.0003
544 WOUND INFECTION 3 0.0003
545 ANGIOEDEMA 12 0.0003
546 BURNING SENSATION 19 0.0003
547 LIVER DISORDER 12 0.0003
548 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
549 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
550 RASH PAPULAR 6 0.0003
551 TRANSIENT ISCHAEMIC ATTACK 9 0.0003
552 ABDOMINAL PAIN 62 0.0003
553 DRUG DOSE OMISSION 44 0.0003
554 MICTURITION URGENCY 3 0.0003
555 DIABETES MELLITUS 20 0.0003
556 HIP ARTHROPLASTY 4 0.0003
557 MATERNAL DRUGS AFFECTING FOETUS 2 0.0003
558 PERICARDIAL EFFUSION 6 0.0003
559 THERAPY PARTIAL RESPONDER 4 0.0003
560 HAEMORRHOIDS 5 0.0003
561 ADVERSE DRUG REACTION 23 0.0003
562 MULTIPLE ALLERGIES 2 0.0003
563 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
564 INJECTION SITE PAIN 78 0.0003
565 HAEMATOCHEZIA 14 0.0003
566 SINUS DISORDER 5 0.0003
567 NASAL DISCOMFORT 2 0.0003
568 ULCER 4 0.0003
569 OBESITY 4 0.0003
570 HAEMOPTYSIS 7 0.0003
571 NIGHT SWEATS 8 0.0002
572 PAIN 152 0.0002
573 FLATULENCE 14 0.0002
574 BONE MARROW FAILURE 5 0.0002
575 CEREBRAL INFARCTION 6 0.0002
576 HYPERSOMNIA 7 0.0002
577 CARDIOMEGALY 3 0.0002
578 ESCHERICHIA INFECTION 2 0.0002
579 HAIR DISORDER 2 0.0002
580 PHOTOSENSITIVITY REACTION 4 0.0002
581 EYE SWELLING 9 0.0002
582 MENSTRUAL DISORDER 2 0.0002
583 HAIR COLOUR CHANGES 3 0.0002
584 MIGRAINE 23 0.0002
585 HEMIPLEGIA 2 0.0002
586 LIP SWELLING 8 0.0002
587 SKIN IRRITATION 11 0.0002
588 POLLAKIURIA 10 0.0002
589 DYSSTASIA 7 0.0002
590 GAIT INABILITY 8 0.0002
591 DYSPHONIA 14 0.0002
592 DYSARTHRIA 9 0.0002
593 SURGERY 14 0.0002
594 WEIGHT DECREASED 66 0.0002
595 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 4 0.0002
596 COUGH 66 0.0002
597 EATING DISORDER 5 0.0002
598 WHITE BLOOD CELL COUNT INCREASED 9 0.0002
599 ROTATOR CUFF SYNDROME 3 0.0002
600 BACK PAIN 54 0.0002
601 INJECTION SITE INDURATION 3 0.0002
602 PRODUCT DOSE OMISSION ISSUE 68 0.0002
603 MUSCLE STRAIN 2 0.0002
604 HYSTERECTOMY 2 0.0002
605 DRUG INEFFECTIVE 304 0.0002
606 FAECES DISCOLOURED 5 0.0002
607 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
608 INCORRECT DOSE ADMINISTERED BY DEVICE 6 0.0002
609 DERMATITIS ATOPIC 12 0.0002
610 URTICARIA 38 0.0002
611 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
612 ATRIAL FIBRILLATION 22 0.0002
613 DRUG ERUPTION 4 0.0002
614 INJECTION SITE HAEMORRHAGE 18 0.0002
615 TOOTH DISORDER 5 0.0002
616 GALLBLADDER DISORDER 4 0.0002
617 JAUNDICE 6 0.0002
618 SNEEZING 5 0.0002
619 DRY EYE 11 0.0002
620 C-REACTIVE PROTEIN INCREASED 8 0.0002
621 WHEEZING 13 0.0002
622 EXOSTOSIS 2 0.0002
623 CORONARY ARTERY OCCLUSION 3 0.0002
624 INJECTION SITE REACTION 15 0.0002
625 NAUSEA 172 0.0002
626 PYREXIA 75 0.0002
627 IRON DEFICIENCY ANAEMIA 2 0.0002
628 HYPOKALAEMIA 10 0.0002
629 BACTERIAL INFECTION 4 0.0002
630 HEPATIC ENCEPHALOPATHY 2 0.0002
631 GAIT DISTURBANCE 41 0.0002
632 ABDOMINAL PAIN UPPER 44 0.0002
633 FLANK PAIN 2 0.0002
634 ARTERIOSCLEROSIS 2 0.0002
635 FEELING HOT 13 0.0002
636 CARDIAC FAILURE 17 0.0002
637 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
638 GASTROOESOPHAGEAL REFLUX DISEASE 17 0.0002
639 DISEASE RECURRENCE 10 0.0002
640 EYE INFLAMMATION 2 0.0002
641 LETHARGY 12 0.0002
642 BLOOD PRESSURE FLUCTUATION 5 0.0002
643 ACUTE RESPIRATORY FAILURE 4 0.0002
644 AFFECT LABILITY 2 0.0002
645 GLAUCOMA 4 0.0002
646 HYPOAESTHESIA 31 0.0002
647 ATELECTASIS 2 0.0002
648 DIZZINESS POSTURAL 2 0.0002
649 SEPSIS 23 0.0002
650 OEDEMA PERIPHERAL 25 0.0002
651 GASTRIC DISORDER 7 0.0002
652 PNEUMONIA 66 0.0002
653 ALOPECIA 40 0.0002
654 ASTHMA 23 0.0002
655 HYPERTENSION 43 0.0002
656 ABDOMINAL DISTENSION 21 0.0002
657 UPPER LIMB FRACTURE 4 0.0002
658 HAEMORRHAGE INTRACRANIAL 3 0.0002
659 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 11 0.0002
660 CHEST PAIN 37 0.0002
661 PREGNANCY 4 0.0002
662 BRAIN INJURY 2 0.0002
663 CORONARY ARTERY DISEASE 6 0.0002
664 CONTUSION 19 0.0002
665 EYELID PTOSIS 2 0.0002
666 DRY THROAT 2 0.0002
667 NEUTROPHIL COUNT INCREASED 2 0.0002
668 INITIAL INSOMNIA 2 0.0002
669 DEVICE RELATED INFECTION 3 0.0002
670 HELICOBACTER INFECTION 2 0.0002
671 LYMPHOMA 3 0.0002
672 BREAST CANCER 18 0.0002
673 DIPLOPIA 5 0.0002
674 SWOLLEN TONGUE 6 0.0002
675 HEART RATE INCREASED 19 0.0002
676 DYSURIA 7 0.0002
677 GASTRITIS 5 0.0002
678 PRODUCT USE IN UNAPPROVED INDICATION 47 0.0002
679 JOINT DISLOCATION 2 0.0002
680 PREMATURE DELIVERY 3 0.0002
681 SCIATICA 3 0.0002
682 BREAST PAIN 2 0.0002
683 MALAISE 82 0.0002
684 HEREDITARY ANGIOEDEMA 2 0.0002
685 DYSPNOEA EXERTIONAL 7 0.0002
686 POOR QUALITY SLEEP 4 0.0002
687 HOT FLUSH 14 0.0002
688 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
689 OEDEMA 10 0.0002
690 CONDITION AGGRAVATED 56 0.0002
691 BIPOLAR DISORDER 2 0.0002
692 HYPERSENSITIVITY 34 0.0002
693 BLOOD PRESSURE INCREASED 28 0.0002
694 MANIA 3 0.0002
695 FATIGUE 141 0.0002
696 VERTIGO 11 0.0002
697 PROCEDURAL PAIN 5 0.0002
698 COAGULOPATHY 3 0.0002
699 EYE PRURITUS 6 0.0002
700 THERAPEUTIC RESPONSE UNEXPECTED 8 0.0002
701 FISTULA 2 0.0002
702 HEMIPARESIS 3 0.0002
703 DYSPNOEA 100 0.0002
704 CIRCULATORY COLLAPSE 3 0.0002
705 IMPAIRED DRIVING ABILITY 2 0.0002
706 THERAPY CESSATION 9 0.0002
707 HAEMATURIA 6 0.0002
708 INTERNAL HAEMORRHAGE 2 0.0002
709 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
710 RED BLOOD CELL COUNT DECREASED 5 0.0002
711 HERPES ZOSTER 10 0.0002
712 THROMBOSIS 14 0.0002
713 RENAL FAILURE 23 0.0002
714 METASTASES TO LUNG 2 0.0002
715 ORTHOSTATIC HYPOTENSION 3 0.0002
716 MUSCULOSKELETAL PAIN 9 0.0002
717 NEEDLE ISSUE 5 0.0002
718 DEPRESSION 39 0.0002
719 METASTASES TO LIVER 3 0.0002
720 DEPRESSED MOOD 9 0.0002
721 OESOPHAGEAL CARCINOMA 5 0.0002
722 BLOOD IRON DECREASED 2 0.0002
723 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
724 HEPATIC FAILURE 5 0.0002
725 PELVIC PAIN 3 0.0002
726 RESTLESS LEGS SYNDROME 3 0.0002
727 SUICIDE ATTEMPT 10 0.0002
728 HYPERGLYCAEMIA 6 0.0002
729 ACCIDENTAL OVERDOSE 6 0.0002
730 HYPERHIDROSIS 21 0.0002
731 INJECTION SITE RASH 5 0.0002
732 HYPOACUSIS 7 0.0002
733 BLOOD GLUCOSE ABNORMAL 3 0.0002
734 GENERALISED OEDEMA 2 0.0002
735 FEMUR FRACTURE 5 0.0002
736 MENTAL DISORDER 7 0.0002
737 DRY MOUTH 13 0.0002
738 INTENTIONAL PRODUCT USE ISSUE 14 0.0002
739 PRODUCT USE ISSUE 30 0.0002
740 FALL 53 0.0002
741 MYALGIA 27 0.0002
742 UNEVALUABLE EVENT 12 0.0002
743 BRAIN OEDEMA 2 0.0002
744 FOOT FRACTURE 3 0.0002
745 BLOOD URINE PRESENT 3 0.0002
746 CHRONIC KIDNEY DISEASE 12 0.0002
747 GASTRIC ULCER 3 0.0002
748 FEELING JITTERY 3 0.0002
749 HEPATIC CYTOLYSIS 2 0.0002
750 MOOD SWINGS 5 0.0002
751 DEVICE MALFUNCTION 11 0.0002
752 HYPOPHAGIA 4 0.0002
753 MOVEMENT DISORDER 5 0.0002
754 GENITAL HAEMORRHAGE 2 0.0002
755 HIATUS HERNIA 2 0.0002
756 FEELING ABNORMAL 37 0.0002
757 BONE PAIN 9 0.0002
758 MENORRHAGIA 3 0.0002
759 DYSPEPSIA 15 0.0002
760 TINNITUS 7 0.0002
761 SKIN DISCOLOURATION 7 0.0002
762 IMPAIRED HEALING 5 0.0002
763 DISABILITY 3 0.0002
764 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
765 HAEMATOCRIT DECREASED 3 0.0002
766 BLOOD PRESSURE ABNORMAL 3 0.0002
767 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
768 BLOOD PRESSURE DECREASED 10 0.0002
769 DEHYDRATION 20 0.0001
770 SPINAL FRACTURE 3 0.0001
771 PROSTATE CANCER 12 0.0001
772 BLOOD BILIRUBIN INCREASED 4 0.0001
773 TASTE DISORDER 3 0.0001
774 BLINDNESS 6 0.0001
775 PALLOR 4 0.0001
776 MOOD ALTERED 4 0.0001
777 ACUTE HEPATIC FAILURE 2 0.0001
778 TACHYCARDIA 13 0.0001
779 LUNG NEOPLASM MALIGNANT 6 0.0001
780 RIB FRACTURE 3 0.0001
781 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
782 DEVICE ISSUE 13 0.0001
783 RESPIRATORY DISTRESS 4 0.0001
784 INCORRECT DOSE ADMINISTERED 33 0.0001
785 ANXIETY 41 0.0001
786 HYPOMAGNESAEMIA 2 0.0001
787 ROAD TRAFFIC ACCIDENT 6 0.0001
788 APHONIA 2 0.0001
789 PANCYTOPENIA 8 0.0001
790 KNEE ARTHROPLASTY 3 0.0001
791 BLINDNESS UNILATERAL 2 0.0001
792 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
793 VOMITING 66 0.0001
794 BRONCHOSPASM 2 0.0001
795 SYNCOPE 14 0.0001
796 CEREBRAL HAEMORRHAGE 5 0.0001
797 RECTAL HAEMORRHAGE 6 0.0001
798 ANGINA PECTORIS 4 0.0001
799 IMPAIRED QUALITY OF LIFE 2 0.0001
800 INSOMNIA 37 0.0001
801 SEPTIC SHOCK 6 0.0001
802 BLOOD CREATININE INCREASED 9 0.0001
803 INJECTION SITE HAEMATOMA 2 0.0001
804 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
805 PANIC ATTACK 5 0.0001
806 VISUAL IMPAIRMENT 17 0.0001
807 CHEST DISCOMFORT 14 0.0001
808 INJECTION SITE MASS 5 0.0001
809 URINARY INCONTINENCE 4 0.0001
810 DRUG INTOLERANCE 13 0.0001
811 COLITIS ULCERATIVE 6 0.0001
812 COLON CANCER 2 0.0001
813 GLOSSODYNIA 3 0.0001
814 EPISTAXIS 10 0.0001
815 SPEECH DISORDER 7 0.0001
816 PANCREATITIS ACUTE 3 0.0001
817 HEART RATE IRREGULAR 3 0.0001
818 HYPOAESTHESIA ORAL 2 0.0001
819 INTESTINAL OBSTRUCTION 5 0.0001
820 EMOTIONAL DISTRESS 16 0.0001
821 ECONOMIC PROBLEM 2 0.0001
822 RENAL IMPAIRMENT 11 0.0001
823 INSURANCE ISSUE 2 0.0001
824 CEREBROVASCULAR ACCIDENT 22 0.0001
825 SEIZURE 15 0.0001
826 DISTURBANCE IN ATTENTION 7 0.0001
827 RASH PRURITIC 7 0.0001
828 EXPOSURE DURING PREGNANCY 8 0.0001
829 PALPITATIONS 15 0.0001
830 DEPENDENCE 7 0.0001
831 CYANOSIS 2 0.0001
832 ANAPHYLACTIC REACTION 7 0.0001
833 OCULAR HYPERAEMIA 6 0.0001
834 DYSPHAGIA 12 0.0001
835 NEUROPATHY PERIPHERAL 12 0.0001
836 MYOCARDIAL INFARCTION 22 0.0001
837 HYPOTHYROIDISM 4 0.0001
838 HEPATIC CANCER 3 0.0001
839 HAEMORRHAGE 13 0.0001
840 FIBROMYALGIA 3 0.0001
841 AMNESIA 8 0.0001
842 METASTASES TO BONE 2 0.0001
843 EYE DISORDER 4 0.0001
844 ABASIA 3 0.0001
845 URINARY RETENTION 4 0.0001
846 WITHDRAWAL SYNDROME 5 0.0001
847 FACE OEDEMA 2 0.0001
848 HAEMATEMESIS 3 0.0001
849 ANGER 4 0.0001
850 CARDIOVASCULAR DISORDER 3 0.0001
851 ERECTILE DYSFUNCTION 3 0.0001
852 THROMBOCYTOPENIA 13 0.0001
853 WEIGHT INCREASED 26 0.0001
854 RASH GENERALISED 3 0.0001
855 NIGHTMARE 4 0.0001
856 ILL-DEFINED DISORDER 7 0.0001
857 PLEURAL EFFUSION 7 0.0001
858 MUSCLE SPASMS 21 0.0001
859 ASTHENIA 43 0.0001
860 ANHEDONIA 3 0.0001
861 HYPOXIA 4 0.0001
862 SLEEP DISORDER 8 0.0001
863 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
864 HEAD DISCOMFORT 2 0.0001
865 CARDIAC FAILURE CONGESTIVE 9 0.0001
866 MENSTRUATION IRREGULAR 3 0.0001
867 THERAPY INTERRUPTED 8 0.0001
868 ACUTE KIDNEY INJURY 17 0.0001
869 CONSTIPATION 24 0.0001
870 BONE DISORDER 2 0.0001
871 VISION BLURRED 15 0.0001
872 MEMORY IMPAIRMENT 15 0.0001
873 PARAESTHESIA 17 0.0001
874 MENTAL STATUS CHANGES 3 0.0001
875 FEELING COLD 3 0.0001
876 DYSGEUSIA 8 0.0001
877 DECREASED APPETITE 25 0.0001
878 DEMENTIA 3 0.0001
879 RENAL DISORDER 5 0.0001
880 BLOOD CHOLESTEROL INCREASED 5 0.0001
881 SWELLING 10 0.0001
882 OXYGEN SATURATION DECREASED 6 0.0001
883 BLOOD SODIUM DECREASED 2 0.0001
884 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
885 MUSCULOSKELETAL DISORDER 2 0.0001
886 OFF LABEL USE 92 0.0001
887 ANAEMIA 20 0.0001
888 DIZZINESS 52 0.0001
889 DRUG PRESCRIBING ERROR 2 0.0001
890 TREMOR 17 0.0001
891 LUNG DISORDER 5 0.0001
892 LOSS OF CONSCIOUSNESS 13 0.0001
893 RENAL INJURY 3 0.0001
894 DISORIENTATION 4 0.0001
895 IRRITABILITY 6 0.0001
896 CYTOKINE RELEASE SYNDROME 2 0.0001
897 PREMATURE BABY 3 0.0001
898 APHASIA 3 0.0001
899 LACRIMATION INCREASED 3 0.0001
900 SUICIDAL IDEATION 9 0.0001
901 FLUID RETENTION 5 0.0001
902 INJURY ASSOCIATED WITH DEVICE 2 0.0001
903 MUSCULAR WEAKNESS 11 0.0001
904 RESPIRATORY FAILURE 7 0.0001
905 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
906 BONE DENSITY DECREASED 3 0.0001
907 INTENTIONAL DRUG MISUSE 2 0.0001
908 BLOOD GLUCOSE INCREASED 18 0.0001
909 HEAD INJURY 3 0.0001
910 HALLUCINATION, VISUAL 2 0.0001
911 PULMONARY EMBOLISM 9 0.0001
912 PANCREATITIS 5 0.0001
913 METABOLIC ACIDOSIS 3 0.0001
914 LACTIC ACIDOSIS 3 0.0001
915 BALANCE DISORDER 8 0.0001
916 DEEP VEIN THROMBOSIS 6 0.0001
917 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
918 PRODUCT STORAGE ERROR 8 0.0001
919 HOSPITALISATION 14 0.0001
920 FEBRILE NEUTROPENIA 6 0.0001
921 VISUAL ACUITY REDUCED 3 0.0001
922 EXPIRED PRODUCT ADMINISTERED 3 0.0001
923 MEDICATION ERROR 5 0.0001
924 NEOPLASM MALIGNANT 6 0.0001
925 THROAT IRRITATION 4 0.0001
926 CHROMATURIA 2 0.0001
927 DRUG EXPOSURE DURING PREGNANCY 3 0.0001
928 CONFUSIONAL STATE 14 0.0001
929 DELIRIUM 3 0.0001
930 CARDIAC DISORDER 8 0.0001
931 HEART RATE DECREASED 3 0.0001
932 PLATELET COUNT DECREASED 9 0.0001
933 INCORRECT ROUTE OF DRUG ADMINISTRATION 3 0.0001
934 DIABETIC KETOACIDOSIS 2 0.0001
935 INTERSTITIAL LUNG DISEASE 4 0.0001
936 CRYING 3 0.0001
937 MENTAL IMPAIRMENT 2 0.0001
938 ENCEPHALOPATHY 2 0.0001
939 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
940 LEUKOPENIA 4 0.0001
941 HYPOTENSION 16 0.0001
942 SOMNOLENCE 16 0.0001
943 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
944 HAEMOGLOBIN DECREASED 8 0.0001
945 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
946 NERVOUSNESS 4 0.0001
947 BREAST CANCER FEMALE 2 0.0001
948 DEVICE BREAKAGE 3 0.0001
949 ABNORMAL DREAMS 2 0.0001
950 EYE IRRITATION 4 0.0001
951 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
952 AGITATION 5 0.0001
953 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
954 PULMONARY OEDEMA 3 0.0001
955 DRUG ADMINISTRATION ERROR 2 0.0001
956 COGNITIVE DISORDER 3 0.0001
957 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
958 DEATH 55 0.0001
959 COMA 3 0.0001
960 MULTIPLE SCLEROSIS 3 0.0001
961 HIP FRACTURE 2 0.0001
962 RHEUMATOID ARTHRITIS 7 0.0001
963 INFUSION RELATED REACTION 4 0.0001
964 AGGRESSION 3 0.0001
965 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
966 BRADYCARDIA 3 0.0001
967 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
968 TREATMENT NONCOMPLIANCE 3 0.0001
969 EYE PAIN 3 0.0001
970 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
971 OVERDOSE 11 0.0001
972 STOMATITIS 3 0.0000
973 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10 0.0000
974 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
975 FLUSHING 5 0.0000
976 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
977 ADVERSE EVENT 4 0.0000
978 ARRHYTHMIA 2 0.0000
979 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
980 DRUG INTERACTION 6 0.0000
981 NEUTROPENIA 5 0.0000
982 CARDIAC ARREST 3 0.0000
983 INTENTIONAL PRODUCT MISUSE 3 0.0000
984 BLADDER CANCER 2 0.0000
985 INTENTIONAL OVERDOSE 2 0.0000
986 DEVICE DIFFICULT TO USE 2 0.0000
987 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
988 NO ADVERSE EVENT 5 0.0000
989 HALLUCINATION 2 0.0000
990 DISEASE PROGRESSION 2 0.0000